pharmalicensing.com: PR Newswire http://pharmalicensing.com/rss/ Latest market and business intelligence from the leading publishers worldwide. en-us pharmalicensing.com: PR Newswire http://pharmalicensing.com/rss/ http://pharmalicensing.com/images/pharmalicensing_logo.jpg 144 Merck Serono and ZymoGenetics Restructure Partnership GENEVA, Switzerland, September 3 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, and ZymoGenetics, Inc. (NASDAQ: ZGEN), Seattle, United States, today announced... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1619 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1619 Wed, 03 Sep 2008 11:00:00 +0000 Nventa Provides Corporate Update and Advancement Plans for HspE7, Hsp 6/11 and Poly-ICR SAN DIEGO, October 8 /PRNewswire/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN), a company developing innovative therapeutics for the treatment of viral infections and cancer, today provided an... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1887 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1887 Wed, 08 Oct 2008 23:34:00 +0000 WEHI Spin-Out MuriGen Restructures G-CSF Antagonist Program With CSL MELBOURNE, Australia, October 27 /PRNewswire/ -- MuriGen Therapeutics today announced that its collaboration with CSL for the development of a new class of drugs that target arthritis and... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1984 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/1984 Mon, 27 Oct 2008 06:00:00 +0000 Novasep Gains SafeBridge(R) "Potent Compound Safety Certification" for its Le Mans Facility POMPEY, France, September 17 /PRNewswire/ -- Novasep is pleased to announce that its site in Le Mans - France, specialized in the development and manufacturing of Highly Potent Active Pharmaceutical... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3665 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/3665 Thu, 17 Sep 2009 15:00:00 +0000 The Helsinn Group Implements New Organizational Structure LUGANO, Switzerland, January 11 /PRNewswire/ -- Riccardo Braglia has been confirmed as CEO of the Helsinn Group. His role will focus on the Group's fundamental strategic tasks, including internal and... http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4226 http://pharmalicensing.com/redirs/news_rss/public/news/viewNewsML/4226 Mon, 11 Jan 2010 11:00:00 +0000